General Archive

-
Articles, News releases
LifeArc joins the REMEDi4ALL Consortium, a pioneering global platform shaping the future of drug repurposing
LifeArc and the EU-funded project, REMEDi4ALL, have announced a collaboration agreement to strengthen the partnership’s potential to transform and accelerate…
-
News releases
£1million partnership aims to develop new treatments for congenital muscular dystrophy
Researchers from University College London have jointly received a £1 million grant from LifeArc and Muscular Dystrophy UK, to develop…
-
News releases
LifeArc and Neuropeutics Inc join forces to advance a new treatment for MND/ALS
LifeArc has announced a collaboration with Neuropeutics Inc to develop a new small molecule for the treatment of motor neuron…
-
News releases
New AI tool aims to detect early signs of dementia during routine eye tests
Data scientists and clinical researchers are working with high street opticians for the first time to develop a digital tool…
-
News releases
Third global Longitude Prize to be launched in 2025 focusing on ALS
A LifeArc-funded prize to incentivise the use of AI and machine-learning approaches in drug discovery for ALS, a form of…
-
News releases
LifeArc appoints Chief Medical Officer to deliver more scientific breakthroughs for patients
LifeArc has appointed healthcare leader and pharmaceutical industry expert, Dr Jonathan Morgan, as the charity’s first Chief Medical Officer.. Jonathan…
-
News releases
£2.7m infectious disease fund to boost rapid testing, drug trials and innovative specimen storage
Rapid diagnostic tests for deadly global viral threats, repurposing antibiotics to tackle neglected tropical diseases and a potential solution to…
-
News releases
Promising results in clinical trial gives hope to patients with blood disorder
A trial for a cutting-edge cell therapy that could become the first ever treatment for the rare, life-threatening blood disorder…
-
News releases
3 steps LifeArc is taking to tackle antimicrobial resistance before it’s too late
Antimicrobial resistance (AMR) is one of the most urgent public health challenges of our time, threatening not only human health…
-
News releases
£76M investment backing into potential MND treatment, underlines benefit of charity funding
Promising new research to develop gene therapy to treat motor neuron disease and other conditions like dementia secures big investment…
-
News releases
Tackling antimicrobial resistance: LifeArc partners with the University of Cape Town to launch a new Centre for Translational AMR Research
LifeArc has announced a significant £5 million investment to co-establish a new Centre for Translational AMR Research (CTAR) Programme at…
-
News releases
LifeArc launches UK’s first cystic fibrosis Innovation Hub Network
The UK’s first network of Cystic Fibrosis Lung Health Innovation Hubs is being launched to accelerate the development of new…